Multidrug resistance (MDR) in acute myeloid leukemia (AML) with core-binding factor (CBF) abnormalities.

被引：0
|
作者：
Baer, MR [1 ]
O'Loughlin, KL [1 ]
Minderman, H [1 ]
Sait, SN [1 ]
Flood, JJ [1 ]
Sorci, JJ [1 ]
Stewart, CC [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
273
引用
收藏
页码：64A / 64A
页数：1
相关论文
共 50 条
  • [21] Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup
    Hospital, Marie-Anne
    Prebet, Thomas
    Bertoli, Sarah
    Thomas, Xavier
    Tavernier, Emmanuelle
    Braun, Thorsten
    Pautas, Cecile
    Perrot, Aurore
    Lioure, Bruno
    Rousselot, Philippe
    Tamburini, Jerome
    Cluzeau, Thomas
    Konopacki, Johanna
    Randriamalala, Edouard
    Berthon, Celine
    Gourin, Marie-Pierre
    Recher, Christian
    Cahn, Jean-Yves
    Ifrah, Norbert
    Dombret, Herve
    Boissel, Nicolas
    BLOOD, 2014, 124 (08) : 1312 - 1319
  • [22] Title: KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor
    Kohl, Tobias M.
    Schnittger, Susanne
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    ANNALS OF HEMATOLOGY, 2006, 85 : 15 - 15
  • [23] Clinicopathologic Characteristics and Outcome of Acute Myeloid Leukemia with (AML) with Core Binding Factor (CBF) Rearrangements: A Retrospective Study
    Mohamed, Shehab Fareed
    Mulikandathil, Yahya
    Soliman, Dina Sameh
    Abbas, Feryal
    Alshurafa, Awni
    Afana, Mohammad
    Ellahie, Anil Yousaf
    Mudawi, Deena Sideeg
    El Omri, Halima
    Gameil, Amna
    Abuasab, Tareq
    Haddad, Fadi
    Singh, Kalpana
    Kassem, Nancy
    Cherif, Honar
    BLOOD, 2022, 140 : 11651 - 11652
  • [24] SECONDARY GENETIC ABBERATIONS AND THEIR EFFECT ON PROGNOSIS IN CORE BINDING FACTOR - ACUTE MYELOID LEUKEMIA (CBF-AML)
    Markova, J.
    Trnkova, Z.
    Maaloufova, J.
    Stary, J.
    Cetkovsky, P.
    Schwarz, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 203 - 203
  • [25] The clinical spectrum of adult acute myeloid leukemia (AML) associated with core binding factor (CBF) translocations.
    Appelbaum, FR
    Kopecky, KJ
    Slovak, ML
    Gundacker, HM
    Tallman, M
    Kim, H
    Dewald, GW
    Estey, E
    Kantarjian, H
    Pierce, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 563S - 563S
  • [26] Outcomes of different therapies in acute myeloid leukemia patients with core-binding factor
    Zhou, Yile
    Wang, Huafeng
    Jin, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Prognostic Factor Analysis in Core-Binding Factor-positive Acute Myeloid Leukemia
    Jung, Hyun Ae
    Maeng, Chi Hoon
    Park, Silvia
    Kim, Seok Jin
    Kim, Kihyun
    Jang, Jun Ho
    Jung, Chul Won
    ANTICANCER RESEARCH, 2014, 34 (02) : 1037 - 1045
  • [28] Expression of core-binding factor (CBF) fusion genes in clonal evolution of chronic myeloid leukemia (CML).
    Kashani, FR
    Kantarjian, H
    Faderl, S
    O'Brien, S
    Rios, MB
    Cortes, J
    BLOOD, 2004, 104 (11) : 258B - 258B
  • [29] Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia
    Mrozek, Krzysztof
    Marcucci, Guido
    Paschka, Peter
    Bloomfield, Clara D.
    CURRENT OPINION IN ONCOLOGY, 2008, 20 (06) : 711 - 718
  • [30] Dasatinib in core-binding factor acute myeloid leukemia: A promising therapeutic approach
    Srinivasan, Shyam
    EJHAEM, 2024, 5 (05): : 1100 - 1101
12345